Cargando…

A review on PIM kinases in tumors

The Proviral Integration site for Moloney murine leukemia virus (PIM) kinases is serine/threonine kinases that promote growth and survival in multiple cell types, implicated in the pathogenesis of various diseases. Over expression of Pim-1 experimentally leads to tumor formation in mice, whereas the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arrouchi, Housna, Lakhlili, Wiame, Ibrahimi, Azeddine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651028/ https://www.ncbi.nlm.nih.gov/pubmed/31359998 http://dx.doi.org/10.6026/97320630015040

Ejemplares similares

Re-positioning of known drugs for Pim-1 kinase target using molecular docking analysis
por: Arrouchi, Housna, et al.
Publicado: (2019)

Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
por: Bendahou, Mohammed Amine, et al.
Publicado: (2020)

Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches
por: Lakhlili, Wiame, et al.
Publicado: (2016)

Determination and validation of mTOR kinase-domain 3D structure by homology modeling
por: Lakhlili, Wiame, et al.
Publicado: (2015)

Docking analysis of verteporfin with YAP WW domain
por: Kandoussi, Ilham, et al.
Publicado: (2017)

Virtual docking screening and QSAR studies to explore AKT and mTOR inhibitors acting on PI3K in cancers
por: Kandoussi, Ilham, et al.
Publicado: (2020)

AKT1 Polymorphism (rs10138227) and Risk of Colorectal Cancer in Moroccan Population: A Case Control Study
por: Allam, Loubna, et al.
Publicado: (2020)

Significant Association of Polymorphisms in the TCF7L2 Gene with a Higher Risk of Type 2 Diabetes in a Moroccan Population
por: Elhourch, Sarah, et al.
Publicado: (2021)

Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors
por: Allam, Loubna, et al.
Publicado: (2018)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

The Role of PIM Kinases in Pediatric Solid Tumors
por: Julson, Janet Rae, et al.
Publicado: (2022)

Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
por: Jiménez-García, Manuel-Pedro, et al.
Publicado: (2017)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics
por: Wang, Yixin, et al.
Publicado: (2021)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

PIM Kinase as an Executional Target in Cancer
por: Zhang, Xinning, et al.
Publicado: (2018)

Targeting Pim kinases in hematological cancers: molecular and clinical review
por: Bellon, Marcia, et al.
Publicado: (2023)

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
por: Santio, Niina M, et al.
Publicado: (2010)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
por: Clements, Amber N., et al.
Publicado: (2022)

[Retracted] Expression and function of PIM kinases in osteosarcoma
por: Mou, Shuai, et al.
Publicado: (2023)

Pim Kinases: Important Regulators of Cardiovascular Disease
por: Nock, Sophie, et al.
Publicado: (2023)

PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
por: Stafman, Laura L., et al.
Publicado: (2018)

Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor
por: Bullock, Alex N., et al.
Publicado: (2009)

Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma()()
por: Stafman, Laura L., et al.
Publicado: (2018)

KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA
por: Cheng, Fang, et al.
Publicado: (2009)

Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice
por: An, Ningfei, et al.
Publicado: (2013)

Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas
por: Kreuz, S., et al.
Publicado: (2015)

Expression and ERG regulation of PIM kinases in prostate cancer
por: Eerola, Sini K., et al.
Publicado: (2021)

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance
por: Chauhan, Shailender S., et al.
Publicado: (2018)

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011)

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma
por: Nair, Jayakumar R., et al.
Publicado: (2016)

Insulin receptor substrate 1 is a substrate of the Pim protein kinases
por: Song, Jin H., et al.
Publicado: (2016)

The Pim kinases control rapamycin-resistant T cell survival and activation
por: Fox, Casey J., et al.
Publicado: (2005)

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28
por: Toth, Rachel K., et al.
Publicado: (2022)

Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2022)

Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts
por: Santio, Niina M., et al.
Publicado: (2015)

Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy
por: Koike, Akito, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hedh3bevflk8h1p8td5s7h02sv